Sodium Hydroxide → HCID 86732538, Verbindung
Reaktionsgleichung
[Cl:1][C:2]1[C:3]([CH2:12][CH2:13][NH:14][C:15](=[O:26])[C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=2[C:22]([F:25])([F:24])[F:23])=[N:4][CH:5]=[C:6]([C:8]([F:11])([F:10])[F:9])[CH:7]=1.[OH-].[Na+]>CO>[Cl:1][C:2]1[C:3]([CH2:12][CH:13]=[N:14][C:15](=[O:26])[C:16]2[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=2[C:22]([F:23])([F:24])[F:25])=[N:4][CH:5]=[C:6]([C:8]([F:10])([F:9])[F:11])[CH:7]=1Komponenten
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
2.00 g of N-{2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethyl}-2-(trifluoromethyl)benzamide (Int-5), (known from WO 2004/016088), were dissolved in 20 mL of methanol. 1 mL of concentrated bleach was added to the reaction mixture at room temperature. The reaction mixture was stirred for 24 hours at room temperature. 20 mL of a 1N aqueous solution of sodium hydroxide were added to the reaction mixture which was then extracted twice with diethyl ether. The combined organic phases were dried over magnesium sulphate, concentrated in vacuo to yield 1.41 g of crude product which was purified by chromatography on silica gel with ethyl acetate/heptane (3/7 v/v) as eluting phase. 340 mg (17%) of desired N-{2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]ethylidene}-2-(trifluoromethyl)benzamide (Int-6) were obtained, [M+1]=395.
Aufarbeitung
- addition1 mL of concentrated bleach was added to the reaction mixture at room temperature
- extractionwas then extracted twice with diethyl ether
- dry with materialThe combined organic phases were dried over magnesium sulphate
- concentrationconcentrated in vacuo
- customto yield 1.41 g of crude product which
- customwas purified by chromatography on silica gel with ethyl acetate/heptane (3/7 v/v)
- washas eluting phase
Quellen und Nachweise
- ORD-Eintrag
- ord-124d1a98be6849aaa73782c8425bbb2c
- Quelldatensatz
- uspto-grants-2016_04
- Patentnummer
- US09301526B2
Notizen zur Reaktion
Wird geladen…